Instil Bio/$TIL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Instil Bio
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
Ticker
$TIL
Sector
Primary listing
Employees
17
Headquarters
Website
Instil Bio Metrics
BasicAdvanced
$52m
-
-$7.04
1.91
-
Price and volume
Market cap
$52m
Beta
1.91
52-week high
$33.83
52-week low
$5.67
Average daily volume
21k
Financial strength
Current ratio
39.869
Quick ratio
15.795
Long term debt to equity
76.785
Total debt to equity
76.953
Interest coverage (TTM)
-7.07%
Profitability
EBITDA (TTM)
-44.397
Management effectiveness
Return on assets (TTM)
-12.69%
Return on equity (TTM)
-37.07%
Valuation
Price to book
0.47
Price to tangible book (TTM)
0.47
Price to free cash flow (TTM)
-1.541
Free cash flow yield (TTM)
-64.89%
Free cash flow per share (TTM)
-5.016
Growth
Earnings per share change (TTM)
-41.21%
3-year earnings per share growth (CAGR)
-41.33%
What the Analysts think about Instil Bio
Analyst ratings (Buy, Hold, Sell) for Instil Bio stock.
Instil Bio Financial Performance
Revenues and expenses
Instil Bio Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs